Career Development Program

职业发展计划

• 批准号: 8485830
• 负责人: SHASHIKANT LELE
• 金额: $ 10.76万
• 依托单位: ROSWELL PARK CANCER INSTITUTE CORP
• 依托单位国家: 美国
• 财政年份: 2013
• 资助国家: 美国
• 起止时间: 2013-09-18 至 2018-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8485830
• 关键词: Advocate; Award; Clinical; Development; Disorder by Site; Faculty; Funding; Goals; Group Meetings; Individual; Malignant neoplasm of ovary; Mentors; Nursing Faculty; Patients; Population Programs; Process; Recommendation; Research; Research Personnel; Research Training; Resources; Series; Specimen; Structure; Study Section; Target Populations; Tissues; United States National Institutes of Health; University of Pittsburgh Cancer Institute; anticancer research; career; career development; experience; interest; meetings; next generation; novel; population based; professor; programs

The purpose of the Career Developmental Program (CDP) of the RPCI-UPCI Ovarian Cancer SPORE is to support the career development of junior researchers in translational ovarian cancer research. The target population for the program is outstanding entry-level (i.e. Assistant Professor) scientific and clinical faculty, but in some cases may include senior postdoctoral or clinical fellows with exceptional potential for independent research careers, or established investigators wishing to refocus their careers on translational ovarian cancer research. A secondary goal of the CDP is to promote the diversity of ovarian cancer researchers, by encouraging the recruitment of outstanding individuals from underrepresented groups. The CDP will be supported both by RPCI-UPCI Ovarian Cancer SPORE funds and matching institutional funds from RPCI and UPCI. The CDP serves as a structured mechanism for identifying outstanding candidates through an open and competitive application and review process, and matching the resulting awardees with experienced mentors. The CDP Leaders will convene a NIH format study section and assign NIH R21-type applications to two scientific and one patient advocate reviewers. Review results will be summarized in the Administrative Core and submitted to the Internal Advisory Board for recommendations for funding. Successful applications will be funded at the level of $50,000 per year for of two years (total award $100,000). We anticipate to fund three to five awards per year depending on the funding year. CDP awardees will be provided full access to the RPCI-UPCI Ovarian Cancer SPORE Core resources, including tissue specimens and statistical support. The CDP will directly facilitate career development through: i) a constructive proposal review by the RPCI-UPCI Ovarian Cancer SPORE Executive Committee and Internal Advisory Board, which are composed of talented investigators with expertise in basic, clinical, and population-based research, ii) research training with a mentor chosen from among a diverse faculty with broad expertise in academic career development, and iii) access to development/enrichment programs, including ovarian cancer disease site research group meetings, periodic SPORE meetings, seminar series, and RPCI-UPCI Ovarian Cancer SPORE annual retreats. In summary, the CDP provides a vital mechanism for the development of the next generation of translational ovarian cancer researchers at RPCI and UPCI.

RPCI-UPCI卵巢癌SPORE的职业发展计划（CDP）的目的是支持初级研究人员在转化卵巢癌研究中的职业发展。该计划的目标人群是优秀的入门级（即助理教授）科学和临床教师，但在某些情况下可能包括高级博士后或临床研究员，他们具有独立研究事业的特殊潜力，或希望将其职业生涯重新聚焦于转化卵巢癌研究的既定研究人员。CDP的第二个目标是促进卵巢癌研究人员的多样性，鼓励从代表性不足的群体中招募杰出的个人。CDP将得到RPCI-UPCI卵巢癌SPORE基金以及RPCI和UPCI的配套机构基金的支持。CDP是一个结构化的机制，通过公开和竞争性的申请和审查过程来确定优秀的候选人，并将获奖者与经验丰富的导师相匹配。CDP领导人将召集NIH格式研究部分，并将NIH R21类型的申请分配给两名科学评审员和一名患者倡导评审员。审查结果将汇总在行政核心文件中，并提交给内部咨询委员会，供其提出供资建议。成功的申请将在两年内每年获得50，000美元的资助（总奖金为100，000美元）。我们预计每年资助三到五个奖项，具体取决于资助年份。CDP获奖者将获得RPCI-UPCI卵巢癌孢子核心资源的完整访问权限，包括组织标本和统计支持。CDP将通过以下方式直接促进职业发展：i）RPCI-UPCI卵巢癌SPORE执行委员会和内部咨询委员会的建设性提案审查，该委员会由具有基础，临床和基于人口的研究专业知识的优秀研究人员组成，ii）从具有学术职业发展广泛专业知识的多元化教师中选择导师进行研究培训，和iii）获得开发/富集计划，包括卵巢癌疾病现场研究小组会议、定期SPORE会议、系列研讨会和RPCI-UPCI卵巢癌SPORE年度务虚会。总之，CDP为RPCI和UPCI的下一代转化性卵巢癌研究人员的发展提供了重要机制。